Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Leukemia|January 5, 2023
Molecular profiling of EBV associated diffuse large B-cell lymphomaFabian Frontzek, Annette M Staiger, Ramona Wullenkord, et al.
Blood|April 20, 2021
Dimethyl fumarate induces ferroptosis and impairs NF-κB/STAT3 signaling in DLBCLAnja Schmitt, Wendan Xu, Philip Bucher, et al.
Frontiers in Immunology|August 21, 2023
Activity of tafasitamab in combination with rituximab in subtypes of aggressive lymphomaMaria Patra-Kneuer, Gaomei Chang, Wendan Xu, et al.
Blood|November 1, 2014
Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphomaAndre Weilemann, Michael Grau, Tabea Erdmann, et al.
The EMBO Journal|August 31, 2016
Myeloid leukemia with transdifferentiation plasticity developing from T-cell progenitorsPia Riemke, Melinda Czeh, Josephine Fischer, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 8, 2014
Mapping of transcription factor motifs in active chromatin identifies IRF5 as key regulator in classical Hodgkin lymphomaStephan Kreher, M Amine Bouhlel, Pierre Cauchy, et al.
Blood|February 17, 2017
Sensitivity to PI3K and AKT inhibitors is mediated by divergent molecular mechanisms in subtypes of DLBCLTabea Erdmann, Pavel Klener, James T Lynch, et al.
Blood|November 20, 2016
B-cell receptor-driven MALT1 activity regulates MYC signaling in mantle cell lymphomaBeiying Dai, Michael Grau, Mélanie Juilland, et al.
Leukemia|August 10, 2023
Novel insights into the pathogenesis of follicular lymphoma by molecular profiling of localized and systemic disease formsSabrina Kalmbach, Michael Grau, Myroslav Zapukhlyak, et al.
Leukemia|March 29, 2018
The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphomaNikolai Schleussner, Olaf Merkel, Mariantonia Costanza, et al.
Pageof 5